Mistletoe extract therapy, widely used in Europe and gaining attention in India, is a complementary approach in cancer care. Developed by ABNOBA GmbH, a trusted German pharmaceutical company, mistletoe injections aim to support the immune system and improve the well-being of patients undergoing conventional treatments like chemotherapy or radiation.
While generally well-tolerated, mistletoe injections can cause some side effects — most of which are mild and temporary. The most common reaction is local irritation at the injection site. This may include redness, warmth, swelling, or mild itching. These effects are usually harmless and often indicate that the body is responding to the therapy.
Some patients report flu-like symptoms such as mild fever, chills, or fatigue after an injection. These signs are typically short-lived and may subside as the treatment progresses. Such immune responses are considered part of the therapeutic effect of mistletoe extract.
In rare cases, mistletoe injections may cause stronger reactions like high fever, allergic responses, or hypersensitivity. These instances require immediate medical attention and a reassessment of the dosage or treatment plan.
Because reactions vary from person to person, it's essential that mistletoe therapy is administered by trained healthcare professionals. ABNOBA GmbH places a strong emphasis on safety, quality control, and scientific validation in its mistletoe products.
If you're considering mistletoe therapy as part of an integrative cancer care plan, consult your oncologist to evaluate its suitability for your specific condition and monitor for side effects throughout the course of treatment.
